MRI of infiltrative lung disease: comparison with pathologic findings

S L Primack1, J R Mayo, T E Hartman

  • 1Department of Radiology, University of British Columbia, Vancouver, Canada.

Abstract

Insights

Magnetic Resonance Imaging (MRI) findings closely correlate with lung biopsy results in chronic infiltrative lung disease. MRI parenchymal opacification often indicates reversible inflammation, while reticulation suggests irreversible fibrosis.

Area of Science:

  • Radiology
  • Pulmonary Medicine
  • Pathology

Background:

  • Chronic infiltrative lung diseases present diagnostic challenges.
  • Accurate differentiation between active inflammation and fibrosis is crucial for patient management.
  • Non-invasive imaging modalities are sought to complement histopathological analysis.

Purpose of the Study:

  • To compare Magnetic Resonance Imaging (MRI) findings with histopathologic results in patients diagnosed with chronic infiltrative lung disease.

Main Methods:

  • A cohort of 22 consecutive patients underwent both MRI and lung biopsy within a median of 4 days.
  • Biopsies included 15 open lung biopsies (idiopathic pulmonary fibrosis, extrinsic allergic alveolitis, miscellaneous) and 7 transbronchial biopsies (sarcoidosis, miscellaneous).
  • All MRI scans were performed at 1.5 T using cardiac-gated T1-, proton density-, and T2-weighted spin-echo sequences.

Main Results:

  • Predominant MRI findings included parenchymal opacification (n=12), reticulation (n=3), and nodularity (n=3).
  • Parenchymal opacification often represented active inflammation (12/14 patients), while reticulation consistently indicated fibrosis (5/5 patients).
  • Nodular patterns were associated with sarcoidosis (3/3 patients).

Conclusions:

  • MRI findings demonstrate a strong correlation with histopathologic diagnoses in chronic infiltrative lung disease.
  • Parenchymal opacification on MRI typically suggests reversible inflammatory processes.
  • Reticulation observed on MRI is a reliable indicator of irreversible pulmonary fibrosis.